Dec 09, 2024
Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW
Dec 05, 2024
Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care
Dec 02, 2024
Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment
Nov 27, 2024
Lunit Inks Partnership with Salud Digna to Advance AI in Medical Imaging
Nov 18, 2024
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Nov 13, 2024
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France's Largest Radiology Network
Oct 23, 2024
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance
Sep 10, 2024
Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024
Sep 09, 2024
Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing
Sep 03, 2024
Immune Phenotyping Identified as Promising Predictive Biomarker by Lunit AI in Biliary Tract Cancer - New publication in CCR
Aug 06, 2024
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study
Jul 22, 2024
Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program
Jul 09, 2024
Lunit Appoints Volpara CEO Teri Thomas as Chief Business Officer of Cancer Screening Group
May 24, 2024
Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response
May 20, 2024
Lunit Achieves Historic Milestone: 100 Peer-Reviewed Papers Published on Its AI Medical Imaging Suite
Apr 08, 2024
Lunit's AI Demonstrates Up to 70% Workload Reduction and Enhanced Accuracy in Breast Cancer Screening: Study in European Radiology Reveals
Mar 26, 2024
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients
Mar 14, 2024
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research
Mar 13, 2024
Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured
Mar 11, 2024
Lunit Expands AI Medical Imaging Solutions in East & Southeast Asia: Partners with Chung Shan Medical University and Gleneagles Hospital Singapore